...
首页> 外文期刊>Annals of Surgical Oncology >Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma
【24h】

Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma

机译:高发性乳头状甲状腺微癌的BRAFV600E 差异突变状态分析

获取原文
获取原文并翻译 | 示例
           

摘要

Papillary thyroid cancers often occur as microcarcinoma. Some papillary thyroid microcarcinoma (PTMC) have been considered to be high aggressive according to advanced disease stages, extrathyroidal extension, and severe cervical lymph node metastasis. Although several factors are thought to predict the occurrence of aggressiveness from PTMCs, the origin of aggressiveness has been rarely studied. To answer this question, the correlation between BRAFV600E mutation and high aggressive PTMCs was investigated. The clinicopathological characteristic of totally 64 cases of PTMCs was investigated and the BRAFV600E mutational status of them was identified. BRAFV600E mutation was exclusively detected in PTMCs (37.5%). The data provided no correlation between the occurrence of BRAFV600E mutations and clinicopathological parameters, such as sex, age, and tumor-like lesions combination. The prevalence of BRAFV600E mutation of PTMCs with high aggressiveness (advanced disease stages, extrathyroidal extension, and nodal metastasis) was significantly higher (p < 0.05) than that of PTMCs without aggressive behavior. The BRAFV600E mutated PTMCs exhibited signs of higher aggressiveness than PTMCs without the mutation. BRAFV600E mutation may be a marker of high aggressiveness in PTMCs.
机译:甲状腺乳头状癌常以微癌的形式出现。根据疾病的进展阶段,甲状腺外扩展和严重的颈部淋巴结转移,一些甲状腺乳头状甲状腺癌(PTMC)被认为具有高侵袭性。尽管认为有几种因素可以预测PTMC发生侵略性,但很少研究侵略性的起源。为了回答这个问题,研究了BRAFV600E 突变与高侵袭性PTMC之间的相关性。研究了总共64例PTMC的临床病理特征,并确定了它们的BRAFV600E 突变状态。仅在PTMC中检测到BRAFV600E 突变(37.5%)。资料表明,BRAFV600E 突变的发生与性别,年龄和肿瘤样病变组合等临床病理参数无关。具有高度攻击性(疾病分期,甲状腺外扩展和淋巴结转移)的PTMC的BRAFV600E 突变的患病率显着高于(p <0.05)无攻击行为的PTMC。与没有突变的PTMC相比,BRAFV600E 突变的PTMC具有更高的侵略性。 BRAFV600E 突变可能是PTMCs高侵袭性的标志。

著录项

  • 来源
    《Annals of Surgical Oncology》 |2009年第2期|240-245|共6页
  • 作者单位

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

    Department of Thyroid ampamp Neck Tianjin Medical University Cancer Hospital Tianjin China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号